CONTEXTVISION AB (CONTX.OL) Fundamental Analysis & Valuation

OSL:CONTX • SE0014731154

3.09 NOK
+0.09 (+3%)
Last: Mar 11, 2026, 07:00 PM

This CONTX.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall CONTX gets a fundamental rating of 5 out of 10. We evaluated CONTX against 12 industry peers in the Health Care Technology industry. CONTX has an average financial health and profitability rating. CONTX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. CONTX.OL Profitability Analysis

1.1 Basic Checks

  • In the past year CONTX was profitable.
  • In the past year CONTX had a positive cash flow from operations.
  • CONTX had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years CONTX had a positive operating cash flow.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

1.2 Ratios

  • The Return On Assets of CONTX (0.61%) is comparable to the rest of the industry.
  • CONTX's Return On Equity of 0.83% is in line compared to the rest of the industry. CONTX outperforms 50.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.30%, CONTX is in line with its industry, outperforming 41.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CONTX is significantly above the industry average of 8.30%.
  • The 3 year average ROIC (20.44%) for CONTX is well above the current ROIC(0.30%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROIC 0.3%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • CONTX's Profit Margin of 0.69% is in line compared to the rest of the industry. CONTX outperforms 50.00% of its industry peers.
  • CONTX's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 0.36%, CONTX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CONTX has declined.
  • The Gross Margin of CONTX (97.37%) is better than 91.67% of its industry peers.
  • CONTX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

5

2. CONTX.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
  • Compared to 1 year ago, CONTX has about the same amount of shares outstanding.
  • The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for CONTX is higher compared to a year ago.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • CONTX has a debt to FCF ratio of 62.32. This is a negative value and a sign of low solvency as CONTX would need 62.32 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 62.32, CONTX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
  • A Debt/Equity ratio of 0.10 indicates that CONTX is not too dependend on debt financing.
  • CONTX's Debt to Equity ratio of 0.10 is in line compared to the rest of the industry. CONTX outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Altman-Z N/A
ROIC/WACC0.04
WACC6.99%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • CONTX has a Current Ratio of 4.28. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.28, CONTX belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • CONTX has a Quick Ratio of 4.23. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 4.23, CONTX belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.23
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

3. CONTX.OL Growth Analysis

3.1 Past

  • The earnings per share for CONTX have decreased strongly by -96.77% in the last year.
  • The earnings per share for CONTX have been decreasing by -41.36% on average. This is quite bad
  • The Revenue for CONTX has decreased by -15.61% in the past year. This is quite bad
  • Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 3.08% on average per year.
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%

3.2 Future

  • CONTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 188.45% yearly.
  • Based on estimates for the next years, CONTX will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y1100%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
EPS Next 5YN/A
Revenue Next Year7.55%
Revenue Next 2Y4.61%
Revenue Next 3Y3.64%
Revenue Next 5Y2.7%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 0.2 0.3 0.4 0.5

3

4. CONTX.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 309.00 indicates a quite expensive valuation of CONTX.
  • CONTX's Price/Earnings ratio is in line with the industry average.
  • CONTX is valuated expensively when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 28.54, CONTX can be considered very expensive at the moment.
  • CONTX's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.27, CONTX is valued at the same level.
Industry RankSector Rank
PE 309
Fwd PE 28.54
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • CONTX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CONTX is more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1126.09
EV/EBITDA N/A
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

  • CONTX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CONTX may justify a higher PE ratio.
  • A more expensive valuation may be justified as CONTX's earnings are expected to grow with 188.45% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y324.26%
EPS Next 3Y188.45%

6

5. CONTX.OL Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
  • The stock price of CONTX dropped by -22.81% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • CONTX's Dividend Yield is rather good when compared to the industry average which is at 2.10. CONTX pays more dividend than 83.33% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CONTX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

CONTX.OL Fundamentals: All Metrics, Ratios and Statistics

CONTEXTVISION AB

OSL:CONTX (3/11/2026, 7:00:00 PM)

3.09

+0.09 (+3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-19
Earnings (Next)05-08
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap239.07M
Revenue(TTM)110.28M
Net Income(TTM)762.00K
Analysts40
Price Target4.08 (32.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.09%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.79%
Revenue NY rev (3m)1.79%
Valuation
Industry RankSector Rank
PE 309
Fwd PE 28.54
P/S 2.06
P/FCF 1126.09
P/OCF 51.22
P/B 2.47
P/tB 2.53
EV/EBITDA N/A
EPS(TTM)0.01
EY0.32%
EPS(NY)0.11
Fwd EY3.5%
FCF(TTM)0
FCFY0.09%
OCF(TTM)0.06
OCFY1.95%
SpS1.5
BVpS1.25
TBVpS1.22
PEG (NY)0.28
PEG (5Y)N/A
Graham Number0.53
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROCE 0.39%
ROIC 0.3%
ROICexc 0.96%
ROICexgc 1.03%
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
FCFM 0.18%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
ROICexc(3y)77.73%
ROICexc(5y)111.49%
ROICexgc(3y)103.93%
ROICexgc(5y)184.88%
ROCE(3y)26.61%
ROCE(5y)48.75%
ROICexgc growth 3Y-81.88%
ROICexgc growth 5Y-66.49%
ROICexc growth 3Y-79.52%
ROICexc growth 5Y-59.81%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 3.84%
Interest Coverage 0.99
Cash Conversion N/A
Profit Quality 26.51%
Current Ratio 4.28
Quick Ratio 4.23
Altman-Z N/A
F-Score5
WACC6.99%
ROIC/WACC0.04
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.73%
Cap/Sales(5y)4.01%
Profit Quality(3y)87.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
EPS Next Y1100%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%
Revenue Next Year7.55%
Revenue Next 2Y4.61%
Revenue Next 3Y3.64%
Revenue Next 5Y2.7%
EBIT growth 1Y-98.68%
EBIT growth 3Y-78.36%
EBIT growth 5Y-61.27%
EBIT Next Year2775%
EBIT Next 3Y208.99%
EBIT Next 5YN/A
FCF growth 1Y-99.31%
FCF growth 3Y-78.75%
FCF growth 5Y-57.02%
OCF growth 1Y-86.52%
OCF growth 3Y-44.44%
OCF growth 5Y-27.59%

CONTEXTVISION AB / CONTX.OL FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 3 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


What is the profitability of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 6 / 10.


What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?

The financial health rating of CONTEXTVISION AB (CONTX.OL) is 5 / 10.


What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to grow by 1100% in the next year.